Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06934356 · ClinicalTrials.gov registry record · NA

Subcortical Arousal in Perceptual Awareness

A NA study of Epilepsy, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
72
Enrollment target
8
Study locations

NCT06934356 is a NA study of Epilepsy that is actively recruiting participants, run by Yale University. The registered enrollment target is 72 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (92% lower). The trial reports 8 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06934356, a NA study of Epilepsy, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
72 participants
Enrollment target
8
Study locations

Study Summary

The study is a multi-site study and will be conducted at up to 11 investigative sites in the United States. The study will investigate subcortical arousal circuits in visual perception using techniques with complementary strengths based on promising initial studies.

Conditions Studied

Interventions

  • DEVICE EEG
  • DEVICE Eye Tracking
  • DEVICE Behavioral task

Study Locations (8)

Connecticut

  • Yale School of Medicine - New Haven

Kansas

  • University of Kansas Medical Center - Kansas City

Massachusetts

  • Massachusetts General Hospital - Boston

Minnesota

  • Mayo Clinic - Rochester

New Hampshire

  • Dartmouth Hitchcock Medical Center - Lebanon

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

Tennessee

  • Vanderbilt University Medical Center - Nashville

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2025-10-13
Est. Completion 2030-12
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT06934356

The ClinicalTrials.gov registry entry for NCT06934356 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (92% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 3 interventions - of which EEG is the first listed.

NCT06934356 reports 8 study locations spanning 8 distinct geographic areas - top geographies include Connecticut, Kansas, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06934356 about?

NCT06934356 is a clinical study titled "Subcortical Arousal in Perceptual Awareness". The study is a multi-site study and will be conducted at up to 11 investigative sites in the United States. The study will investigate subcortical arousal circuits in visual perception using techniques with complementary strengths based on promising initial studies.

What is the current status of trial NCT06934356?

This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2025-10-13. Estimated completion is 2030-12.

What conditions does trial NCT06934356 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT06934356?

The interventions under investigation include: EEG (DEVICE), Eye Tracking (DEVICE), Behavioral task (DEVICE).

Who is sponsoring clinical trial NCT06934356?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06934356 being conducted?

This trial has 8 study locations across Connecticut, Kansas, Massachusetts, Minnesota, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.